ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,028Medicare Part D Prescriptions Filled, Including Refills

Rank: 212 out of 670

$409K Total Retail Price of All Prescriptions

Rank: 261 out of 670

394 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 394 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

22% of this provider’s 394 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

0% of this provider’s 6,290 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
HYDROCODONE-ACETAMINOPHEN 532 392 S3 1 1
WARFARIN SODIUM 447 315 2 13
METOPROLOL TARTRATE 306 258 3 9
FUROSEMIDE 251 211 4 6
LEVOTHYROXINE SODIUM 225 198 5 2
LISINOPRIL 196 139 6 3
DONEPEZIL HCL 166 157 7 31
NAMENDA 159 139 8 54
AMLODIPINE BESYLATE 158 141 9 7
SERTRALINE HCL 152 126 10 22
SIMVASTATIN 150 111 11 4
ALBUTEROL SULFATE 138 131 12 133
OMEPRAZOLE 126 104 13 5
MIRTAZAPINE 113 100 14 59
GABAPENTIN 109 45 15 11
METOPROLOL SUCCINATE 97 70 16 12
DIGOXIN 97 83 16 46
RANITIDINE HCL 92 92 18 25
PANTOPRAZOLE SODIUM 86 86 19 41
GENERLAC 82 66 20 187
NEXIUM 78 56 21 14
ONDANSETRON HCL 78 75 21 233
ATORVASTATIN CALCIUM 78 71 21 15
LANTUS 76 45 24 58
POLYETHYLENE GLYCOL 3350 75 52 25 79
OXYCODONE HCL-ACETAMINOPHEN 71 67 S2 26 71
CEFUROXIME 68 61 27 121
QUETIAPINE FUMARATE 68 56 27 84
KLOR-CON M10 65 46 29 112
HYDRALAZINE HCL 61 35 30 147
ESCITALOPRAM OXALATE 56 51 31 78
BACLOFEN 56 0 31 129
CLOPIDOGREL 56 47 31 24
CARBIDOPA-LEVODOPA 54 42 34 101
CITALOPRAM HBR 54 43 34 20
POTASSIUM CHLORIDE 53 43 36 16
OLANZAPINE 53 44 36 143
IPRATROPIUM BROMIDE 52 50 38 248
IPRATROPIUM-ALBUTEROL 52 51 38 136
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 25, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.